– which factor in store closures –decreased 0.7% in its third quarter ended in May, though comparable retail sales rose by 1.9%. Comparable pharmacy sales increased at a faster 3.5% rate.
"We all know that the pharmacy side of the business is strong, but the front end of the store has seen declining comps for what seems like an eternity," said Petrides. Matt Maley, chief market strategist at Miller Tabak, agreed that it is a "cheap" stock. However, he is wary on its potential for long-term gains.
"The stock has been making a series of lower highs and lower lows for five years now. I mean over the last five years, the stock is down 60%, while the market has been up 70%," said Maley during the same "Trading Nation" segment."I don't love it right here, but on a short-term basis traders could see a pop. If these earnings take the stock above $37.